Private Capital Advisors, Inc.

Position in REPL — Replimune Group, Inc.

CIK 1350780 DARIEN, CT

Position in REPL

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$299,620

New position

Shares Held

27,066

first reported quarter

Ownership

0.029%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#94

of 198 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Private Capital Advisors, Inc. holds $1,338,094 across 5 Biotechnology names. REPL ranks #1 (22.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REPL	Replimune Group, Inc. This page	27,066	$299,620
2	MANE	Veradermics, Inc	2,435	$299,358
3	ONC	BeOne Medicines Ltd.	999	$284,685
4	IBRX	ImmunityBio, Inc.	26,978	$236,192
5	REGN	Regeneron Pharmaceuticals, Inc.	350	$218,239

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$299,620	27,066	—	Shares	Sole	2026-07-24
No filing history on record for this holder in this stock.